Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 103 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 1954. Clear
Clear
2T
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy, Taxation/Internal Revenue Code
View →
Q2
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · $220,000.00 income
Copyright/Patent/Trademark, Health Issues
View →
Q2
AMERICAN COLLEGE OF RHEUMATOLOGY for AMERICAN COLLEGE OF RHEUMATOLOGY
2nd Quarter (Apr 1 - June 30) 2026 · Georgia · House · Senate
Health Issues, Budget/Appropriations, Medicare/Medicaid
View →
Q2
AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) for AMERICA'S HEALTH INSURANCE PLANS INC (AHIP)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Insurance, Pharmacy
View →
Q2
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q2
KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate
Defense, Housing, Health Issues, Medicare/Medicaid
View →
Q2
THE NICKLES GROUP, LLC for AMGEN
2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q2
BLUE CROSS AND BLUE SHIELD OF FLORIDA, INC. for BLUE CROSS AND BLUE SHIELD OF FLORIDA INC
2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
2nd Quarter (Apr 1 - June 30) 2026 · Illinois · House · Senate
Manufacturing, Copyright/Patent/Trademark, Taxation/Internal Revenue Code, Trade (domestic/foreign)
View →
Q2
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · House · Senate
Defense, Health Issues, Budget/Appropriations, Copyright/Patent/Trademark
View →
Q2
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
VIZIENT, INC. for VIZIENT INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Trade (domestic/foreign), Tariff (miscellaneous tariff bills)
View →
Q2
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark, Taxation/Internal Revenue Code
View →
Q2
SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL) for SMALL BUSINESS & ENTREPRENEURSHIP COUNCIL (SBE COUNCIL)
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Small Business
View →
Q2
AVENUE SOLUTIONS for AMGEN, INC.
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q2
AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS for AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS
2nd Quarter (Apr 1 - June 30) 2026 · Maryland · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
BLUE CROSS AND BLUE SHIELD ASSOCIATION for BLUE CROSS AND BLUE SHIELD ASSOCIATION
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q2
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy
View →
Q2
GUIDEWELL MUTUAL HOLDING CORPORATION for GUIDEWELL MUTUAL HOLDING CORPORATION
2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate
Medicare/Medicaid, Pharmacy
View →
Q2
APOTEX CORP. for APOTEX CORP.
2nd Quarter (Apr 1 - June 30) 2026 · Florida · House · Senate
Manufacturing, Trade (domestic/foreign), Copyright/Patent/Trademark, Health Issues
View →
Q2
THORN RUN PARTNERS for THE BIOSIMILARS FORUM
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $100,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
TIBER CREEK GROUP for AMGEN INC
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
BCBSM, INC. for BCBSM INC
2nd Quarter (Apr 1 - June 30) 2026 · Minnesota · House · Senate
Health Issues, Budget/Appropriations, Pharmacy
View →
Q2
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q2
PRIME THERAPEUTICS for PRIME THERAPEUTICS
2nd Quarter (Apr 1 - June 30) 2026 · Minnesota · House · Senate
Health Issues, Medicare/Medicaid
View →
Page 1 of 5 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem